Here’s a Thought! 30 July, 2020, by Vladimir Rojankovski, Senior Analyst, Grand Capital Eastman Kodak said yesterday it signed a letter of interest for almost $800 million loan from the U.S. International Development Finance Corporation. The company will use the money to ramp up the development of Kodak Pharmaceuticals, a division tasked with addressing a national shortage of critical pharmaceutical components, including for the ongoing COVID-19 vaccine trials. Shares of Eastman Kodak surged 143 percent yesterday to trade at $19.29, after touching a new 52-week high of $21.32 earlier. The number of Robinhood investors holding Kodak stock grew nearly eightfold from Tuesday morning to Wednesday afternoon amid the company's extraordinary rally. “COVID-19 vaccine” is a magic word combination for markets. Almost any company can reasonably expect to capitalize on reporting anything to do with this kind of infection studies or applications. We expect more low-key market participants to use this magic tool for jumping from nowhere into their moments of glory.
wrong the insiders took position prior to news and got out yesterday at way oversold this was way over bought on bad plan look everywhere if people do not get out before dump good luck. the CEO stated wont happen for another 3-5 years if at all as in by that time maybe its no loger need and this was a loan a net debit.